• Mr.Xia
    Tel: +86-0512-62956066

  • Mr.Xiang Fang
    Tel: 15862346825

  • Mobile:15501520501
  • Tel:+86-0512-62956066
  • Fax:+86-512-69561920
  • URL:http://www.chiralquest.com
  • Province/state:Jiang Su
  • City:Su Zhou
  • Street:B1/9, 218 Xinghu Street, Suzhou Industrial Park
  • MaxCard:
Home > Products >  sitagliptin intermediate with innovative process and resonanle price,

sitagliptin intermediate with innovative process and resonanle price, CAS NO.486460-00-8

  • Product Details

Keywords

  • (R)-3-(tert-butoxycarbonylamino)-4-(2,4,5-trifluorophenyl) butanoic acid
  • sitagliptin intermediate
  • sitagliptin intermediate

Quick Details

  • ProName: sitagliptin intermediate with innovati...
  • CasNo: 486460-00-8
  • Molecular Formula: C15H18F3NO4
  • Appearance: off-white to white powder
  • Application: Sitagliptin intermediate
  • DeliveryTime: as soon as possible once the PO is con...
  • PackAge: as required
  • Port: as required
  • ProductionCapacity: 50 Metric Ton/Year
  • Purity: 99.5%
  • Storage: Room temperature, double PE bags
  • Transportation: as required
  • LimitNum: 1 Kilogram
  • Moisture Content: 0.5%
  • Impurity: 0.2%

Superiority

DMF for this intermediate is available,

The DMF No.is 27115.   we own the patent which was granted in US, Europe India and China ,

The material has been scaled up to tons scale, the process is reliable. 

This material was produced in our Jangxi manufacturing site, this site is very reliable, our customer recoglize it as one of the best intermediate manufacturer in china.

 

Details

Chiral Quest was founded in 2000, we provide chemical development and contract manufacturing services to meet demand at all stages of development (kilo-lab, pilot-plant and commercial scale manufacture).

Chiral Quest has a manufacturing site in Jiangxi province, headquarters and R&D centre located in Suzhou Industrial Park; and three overseas offices located in USA, Europe and India.  We have expertise in asymmetric hydrogenation, multi-step synthesis, coupling reactions and cryogenic reactions.  With 13 granted U.S. patents for asymmetric hydrogenation catalysts and 6 process patents for innovative routes to generic API intermediates.

Chiral Quest’s mission is to create value for the global healthcare industry by using economic and environmentally friendly methods to manufacture single enantiomer pharmaceutical intermediates.

we own the patent and the DMF 

 

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog